Disney+ Hotstar’s latest offering is poised to captivate audiences with a star-studded cast and an intriguing storyline. The second Malayalam web series from the platform, titled “Pharma,” features Nivin Pauly in his first-ever long web series, marking a significant collaboration for the actor. Renowned Bollywood actor Rajit Kapur is also making a return to Malayalam entertainment after a decade, adding to the series’ star power.
“Pharma” is directed by PR Arun, the creative mind behind the feature film “Finals.” With this new series, Arun promises a potent mix of drama and depth that is sure to keep viewers engaged.
The series also boasts a talented crew, with Abhinandan Ramanujam handling cinematography and Jakes Bejoy composing the music. Sreejith Sarang takes charge as the editor, ensuring the storytelling flows seamlessly.
One intriguing aspect of “Pharma” is the promise of surprise cast members. The series is keeping these names under wraps, adding an element of suspense and excitement to the project.
Nivin Pauly, in a recent statement, expressed his enthusiasm for being a part of “Pharma” and the unique universe it creates. He stated, “Really excited to be a part of Pharma and with the universe it creates. I think it’s a story that must be told and shared.”
Rajit Kapur, a forgotten actor from Bollywood, mentioned his excitement about joining “Pharma,” marking 25 years since his role in “Agnisakshi.” His return to Malayalam entertainment is generating a lot of buzz, and fans are eager to see what he brings to the series.
Director PR Arun revealed that “Pharma” draws inspiration from hundreds of true stories. He described the series as a story close to his life and heart, suggesting that it will tackle meaningful and relevant themes.
We’re hiring!
We are hiring two full-time junior to mid-level writers with the option to work remotely. You need to work a 5-hour shift and be available to write. Interested candidates should email their sample articles to [email protected]. Applications without a sample article will not be considered.
